000			02323 a2200613 4500
005			20250514021228.0
264		0	_c20020108
008			200201s 0 0 eng d
022			_a0004-3591
024	7		_a10.1002/1529-0131(200112)44:12<2870::aid-art475>3.0.co;2-y _2doi
040			_aNLM _beng _cNLM
100	1		_aMeroni, P L
245	0	0	_aStatins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. _h[electronic resource]
260			_bArthritis and rheumatism _cDec 2001
300			_a2870-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Antiphospholipid _xpharmacology
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Adhesion _ximmunology
650	0	4	_aCells, Cultured
650	0	4	_aE-Selectin _xgenetics
650	0	4	_aEndothelium, Vascular _xcytology
650	0	4	_aFatty Acids, Monounsaturated _xpharmacology
650	0	4	_aFluvastatin
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aGlycoproteins _ximmunology
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology
650	0	4	_aImmunoglobulin G _xpharmacology
650	0	4	_aImmunoglobulin M _xpharmacology
650	0	4	_aIndoles _xpharmacology
650	0	4	_aIntercellular Adhesion Molecule-1 _xgenetics
650	0	4	_aInterleukin-1 _xpharmacology
650	0	4	_aInterleukin-6 _xgenetics
650	0	4	_aLipopolysaccharides _xpharmacology
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aPhenotype
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aTumor Necrosis Factor-alpha _xpharmacology
650	0	4	_aU937 Cells
650	0	4	_aUmbilical Veins _xcytology
650	0	4	_abeta 2-Glycoprotein I
700	1		_aRaschi, E
700	1		_aTestoni, C
700	1		_aTincani, A
700	1		_aBalestrieri, G
700	1		_aMolteni, R
700	1		_aKhamashta, M A
700	1		_aTremoli, E
700	1		_aCamera, M
773	0		_tArthritis and rheumatism _gvol. 44 _gno. 12 _gp. 2870-8
856	4	0	_uhttps://doi.org/10.1002/1529-0131(200112)44:12<2870::aid-art475>3.0.co;2-y _zAvailable from publisher's website
999			_c11675063 _d11675063